Physician profile
Michael Anders Lundborg
NPI 1487037867
$15,934.18
in general payments reported to CMS, 2019-2025
14 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,443 · 2020: $924 · 2021: $60.31 · 2022: $616 · 2023: $7,795 · 2024: $4,384 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $2,281 · Travel and Lodging: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $2,280.50 |
| Travel and Lodging | $610.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $12,601.20 | 2022-2025 | |
| Paragon 28, INC. | $1,257.35 | 2019 | |
| Arthrex, INC. | $750.55 | 2020 | |
| Smith+Nephew, INC. | $388.17 | 2019-2025 | Stravix, Renasys Go V2 Home, Grafix Pl |
| Fusion Orthopedics USA, LLC | $365.37 | 2025 | |
| Nevro Corp. | $193.51 | 2021-2024 | Senza |
| Cpm Medical Consultants, LLC | $155.25 | 2020 | |
| Organogenesis INC. | $54.59 | 2024-2025 | Puraply Wound Matrix |
| Henry Schein, INC. | $44.25 | 2019 | |
| Depuy Synthes Sales INC. | $27.19 | 2019 | |
| Triad Life Sciences INC. | $26.42 | 2022 | |
| Bioventus LLC | $26.12 | 2019 | |
| Biowound Solutions, INC. | $25.44 | 2025 | Bio-Connekt |
| Paratek Pharmaceuticals, INC. | $18.77 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lundborg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.